DHR Stock Analysis: Buy, Sell, or Hold?
DHR - Danaher Corporation
$218.85
2.94 (1.36%)
▲
5d:
+8.1%
30d:
+13.69%
90d:
+26.26%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Get Alerted When DHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DHR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DHR shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$287.13
Based on 6.7% avg growth
INTRINSIC VALUE TODAY
$178.28
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DHR is currently trading at $218.85, which is considered extended relative to its 30-day fair value range of $191.92 to $208.70. The stock's valuation (Forward PE: 23.5) is in line with its historical norms (22.4). At these levels, the market is pricing in 1.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DHR is in a strong uptrend. The price is approaching resistance at $220.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DHR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DHR is in a strong uptrend. The price is approaching resistance at $220.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DHR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$191.92 -
$208.70
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
24.8%
Protect Your Profits
Holding DHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($227.96)
- NEUTRAL: Market pricing in 1.7% annual earnings growth - fairly valued
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$191.92 -
$208.70
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$199.49
Resistance Level
$220.67
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.54
Wall Street Target
$227.96
(+4.2%)
Revenue Growth (YoY)
5.5%
Earnings Growth (YoY)
59.7%
Profit Margin
16.0%
Valuation Premium vs History
+1.7% premium
PE vs Historical
23.5 vs 22.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.7%
(market-implied from PE analysis)
1-Year Target
$222.57
(+2%)
2-Year Target
$226.35
(+3%)
3-Year Target
$230.20
(+5%)
3-Yr Target (if PE normalizes)
(PE: 24→22)
PE COMPRESSION
$219.06
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 9.3%)
$285.42
(+30%)
Base:
(SPY PE: 20.1, Growth: 9.3%)
$243.36
(+11%)
Bear:
(PE: 17.1, Growth: 9.3%)
$206.86
(-6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 37.75 | Current EPS (TTM): $5.72
Bull Case
$386.03
(+76%)
Analyst growth 62.5%, PE expands to 41.5
Base Case
$350.94
(+60%)
Market implied 62.5%, PE stable at 37.8
Bear Case
$146.82
(-33%)
Severe decline -20.0%, PE contracts to 32.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 6:36 PM ET
Data refreshes hourly during market hours. Next update: 7:36 PM
Data refreshes hourly during market hours. Next update: 7:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DHR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Featured in Portfolios
DHR is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$631 | 41 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 50 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$337 | 38 SELL |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$338 | 49 HOLD |
Advanced DHR Option Strategies
Professional options setups generated by AI based on today's DHR price and gamma walls.
